![Frank Mathias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Mathias
Chief Executive Officer at
OXFORD BIOMEDICA PLC
Net worth: 157 840 $ as of 30/09/2026
Profile
Dr. Frank Mathias is a Chairman at ArcticZymes Technologies ASA, a Chief Executive Officer & Director at Oxford Biomedica Plc, a Chairman at Vfa Bio, a Chairman-Supervisory Board at August Faller GmbH & Co. KG and a Chief Executive Officer at OXB US, Inc. He is on the Board of Directors at Oxford Biomedica Plc, Rentschler Biopharma SE, Seqens SAS, leon-nanodrugs GmbH, LEUKOCARE AG, Mediatum GmbH and Rentschler Biotechnologie Beteiligungs GmbH.
Dr. Mathias was previously employed as an Independent Member-Supervisory Board by MediGene AG, a Member-Executive Board by MediGene AG, a Chief Executive Officer by AMGEN GmbH, a Chief Executive Officer by Dr. Rentschler Holding GmbH & Co. KG, a Manager-International Product by Hoechst AG, and a General Manager by Servier Deutschland GmbH.
He also served on the board at Catherex, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0.02% | 31/12/2025 | 20,000 ( 0.02% ) | 138 690 $ | 30/09/2026 |
| 31/12/2025 | 9,000 ( 0.02% ) | 19 150 $ | 30/09/2026 |
Frank Mathias active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Executive Officer | 27/03/2023 |
| ARCTICZYMES TECHNOLOGIES ASA | Chairman | 26/06/2024 |
August Faller GmbH & Co. KG
 August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Chairman | - |
Vfa Bio | Chairman | - |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Director/Board Member | - |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Director/Board Member | - |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Director/Board Member | - |
Mediatum GmbH | Director/Board Member | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Director/Board Member | 31/03/2023 |
Former positions of Frank Mathias
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Education of Frank Mathias
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in pharmaceutical research and production | Commercial Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seqens SAS
 Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Process Industries |
August Faller GmbH & Co. KG
August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Process Industries |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Health Services |
Servier Deutschland GmbH
 Servier Deutschland GmbH Pharmaceuticals: MajorHealth Technology Engages in research, development and distribution of pharmaceutical products | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Mediatum GmbH | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
Rentschler Biotechnologie Beteiligungs GmbH
Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Vfa Bio |
- Stock Market
- Insiders
- Frank Mathias
